Tue, Jul 22, 2014, 4:06 PM EDT - U.S. Markets closed

Recent

% | $
Click the to save as a favorite.

Cadence Pharmaceuticals, Inc. Message Board

  • jack_mlyn jack_mlyn Mar 28, 2013 5:26 PM Flag

    Give opinions on these thoughts

    for a one product company with no catalysts to have moved up so much ahead of a major event (the Ofirmev patent trial, which starts on May 20) has been perplexing. I wouldn't want to own it ahead of the trial - the litigation has been moving forward and trial will likely not be delayed. My "settlement" scenario valuation, which would be a best case scenario in which CADX settles with generic challenger Exela on the same terms as the PRGO settlement, is ~$5.50. I really can't see upside in any scenario other than a takeout, which is difficult to predict...

 
CADX
13.980.00(0.00%)Mar 18 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.